Skip to main content
Fig. 6 | Genome Biology

Fig. 6

From: Methylation-directed regulatory networks determine enhancing and silencing of mutation disease driver genes and explain inter-patient expression variation

Fig. 6

Key methylation sites describe inter-patient expression variation. a Development of methylation-based models of gene expression variation. b Example models of gene expression variations. Left: Methylation versus expression of the sites consisting the best model of the TNFAIP3 gene. Right: Predicted versus observed expression levels of the TNFAIP3 or the SMO genes across the tumors. SMO model was based on the four sites shown in Fig. S8a. c Fractions of gene-expression models which incorporate methylation data from, positive, negative, or both positive and negative units. d Assessing the prediction power of gene-expression models. Left: Developing of a prediction model for each of the 24 GBM tumors, based on the other 23 tumors. Middle: Example distribution of predicted versus observed expression levels of cancer genes. The full list of distributions is given in Additional file 5. Right: Distributions of predicted versus observed expression levels of driver genes across the 24 tumors. Log 2 of the differences between predicted and observed gene expression levels for driver genes with developed models are shown. Box plots describe the distributions of prediction errors in 24 independent tests

Back to article page